Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced ...

Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global animal and public health, announced today ...

Recent developments in the Molecular Diagnostics space have been aiding key MedTech players like BD (BDX) to boost their business.

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today the launch of their Vector Smart™ NAM-e multiplex ...

Bringing sensitive TB diagnosis and drug susceptibility testing closer to patients is a key priority for global TB control, but requires robust point-of-care diagnostic tests that are easily ...

General concepts in molecular diagnostics Single-molecule versus high-throughput strategies The classic paradigm that the DNA of the cell will determine its fate is too simplistic.